Managing Long COVID - Addressing Common Questions Regarding Long COVID
From the beginning of the pandemic there were many individuals infected with the SARS-CoV-2 virus who had symptoms that persisted. While some of this was thought to be due to organ damage due to hospitalization, there are people who had mild symptoms and experienced debilitating symptoms for months and in some cases years after the initial infection. Long COVID, also called post-acute COVID-19 syndrome (PACS), is the persistence of symptoms beyond the acute infection. In the second of this two-part webinar, international and national experts will address the most common questions regarding long COVID.
This program has been supported by Moderna.
Ali Reza Ladak, BSc (Pharm), RPh
Peter J. Lin, MD, CCFP
David Strain, MBChB, MD, FRCP
Upon completion of this continuing education program participants will be better able to:
- Address common questions regarding long COVID
- Discuss the current evidence for the management of long COVID
- Describe the impact of long COVID on affected patients